MD480Y - Method for treating acute ulcerative nonspecific colitis - Google Patents

Method for treating acute ulcerative nonspecific colitis

Info

Publication number
MD480Y
MD480Y MDS20110128A MDS20110128A MD480Y MD 480 Y MD480 Y MD 480Y MD S20110128 A MDS20110128 A MD S20110128A MD S20110128 A MDS20110128 A MD S20110128A MD 480 Y MD480 Y MD 480Y
Authority
MD
Moldova
Prior art keywords
day
administered
aminosalicylic acid
solution
during
Prior art date
Application number
MDS20110128A
Other languages
Moldavian (mo)
Romanian (ro)
Inventor
Elvira Andon
Liviu Andon
Original Assignee
Elvira Andon
Liviu Andon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elvira Andon, Liviu Andon filed Critical Elvira Andon
Priority to MDS20110128A priority Critical patent/MD480Z5/en
Publication of MD480Y publication Critical patent/MD480Y/en
Publication of MD480Z publication Critical patent/MD480Z/en
Publication of MD480Z5 publication Critical patent/MD480Z5/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, particularly to proctology and can be used for the treatment of acute ulcerative nonspecific colitis.According to the invention, the claimed method consists in that it is administered 5- aminosalicylic acid in capsules of 1200…4000 mg per day, per os, during one month, solution of 2-(2-methyl-5-nitro1H-imidazole-1-yl)ethanol 500 mg, intravenously, 2 times a day, solution of 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazine-1-yl)-quinoline-3-carboxylic acid 1.0 ml, intravenously, 2 times a day and solution of 5-(aminosulphonyl)N-¢(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide 2.0 ml in the evening, during 7 days, it is carried out the detoxification therapy, transfusion of packed red blood cells, plasma, albumin, at the same time is administered 5-aminosalicylic acid in the form of microclysters, in a day, during one month. In case of affection of rectosigmoid region, the 5-aminosalicylic acid is administered as a gel, 500 mg, once a day, and in case of affection of the colon, the 5-aminosalicylic acid is administered as foam 2 g, 2 times a day.
MDS20110128A 2011-07-07 2011-07-07 Method for treating acute ulcerative nonspecific colitis MD480Z5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20110128A MD480Z5 (en) 2011-07-07 2011-07-07 Method for treating acute ulcerative nonspecific colitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20110128A MD480Z5 (en) 2011-07-07 2011-07-07 Method for treating acute ulcerative nonspecific colitis

Publications (3)

Publication Number Publication Date
MD480Y true MD480Y (en) 2012-02-29
MD480Z MD480Z (en) 2012-09-30
MD480Z5 MD480Z5 (en) 2012-09-30

Family

ID=45815378

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20110128A MD480Z5 (en) 2011-07-07 2011-07-07 Method for treating acute ulcerative nonspecific colitis

Country Status (1)

Country Link
MD (1) MD480Z5 (en)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903914D0 (en) * 1989-11-22 1989-11-22 Draco Ab ORAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
RU2056849C1 (en) * 1992-03-03 1996-03-27 Кириллов Владимир Анатольевич Method for treating the cases of nonspecific ulcerous colitis
RU2141318C1 (en) * 1993-12-01 1999-11-20 Санкио Компани Лимитед Inhibitor of inflammatory cytokine formation, agent for prophylaxis and treatment of gastroenteric tract inflammatory sicknesses and behcet's syndrome, method of prophylaxis and treatment of inflammatory sicknesses and ulcer colitis
ATE383875T1 (en) * 1998-03-17 2008-02-15 Chugai Pharmaceutical Co Ltd PROPHYLACTIC OR THERAPEUTIC AGENTS AGAINST INFLAMMATORY DISEASES OF THE DIGESTIVE TRACT CONTAINING ANTAGONISTIC IL-6 RECEPTOR ANTIBODIES
RU2200007C2 (en) * 1999-03-05 2003-03-10 Научный центр реконструктивной и восстановительной хирургии Восточно-Сибирского научного центра СО РАМН Method for treating patients for nonspecific ulcerating colitis
JP4210454B2 (en) * 2001-03-27 2009-01-21 日本たばこ産業株式会社 Inflammatory bowel disease treatment
RU2165758C1 (en) * 2000-09-04 2001-04-27 Андрей Эдуардович Дорофеев Method for treating ulcerative colitis
RU2318537C2 (en) * 2001-04-06 2008-03-10 Юниверсити Оф Бристоль Application of cd25-binding molecules for treatment of steroid-resistant patients
EP1448205B1 (en) * 2001-10-05 2011-03-23 Zalicus Inc. Combinations for the treatment of immunoinflammatory disorders
RU2215546C1 (en) * 2002-03-29 2003-11-10 Алтайский государственный медицинский университет Method for treating inspecific ulcerous colitis
SG192300A1 (en) * 2003-01-28 2013-08-30 Ironwood Pharmaceuticals Inc Methods and compositions for the treatment of gastrointestinal disorders
CN1914220A (en) * 2004-02-03 2007-02-14 日本新药株式会社 Prodrug comprising 5-aminosalicylate glycoside
CN101912382B (en) * 2004-03-23 2012-11-21 冬姆佩股份公司 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
KR101531116B1 (en) * 2004-04-28 2015-06-23 누트리션 사이언스 파트너스 리미티드 Crude extracts from andrographis paniculata
RU2328298C1 (en) * 2007-03-30 2008-07-10 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) Method of non-specific ulcerative colitis treatment
RU2394571C1 (en) * 2009-05-14 2010-07-20 Государственное бюджетное учреждение здравоохранения города Москвы "Городская клиническая больница № 24" Департамента здравоохранения города Москвы Method of treating inflammatory intestinal diseases
RU2419443C1 (en) * 2009-12-08 2011-05-27 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Method of treating patients with ulcerative colitis
RU2460554C1 (en) * 2011-01-12 2012-09-10 Петр Леонидович Щербаков Method of ulcerative colitis and crohn's disease therapy

Also Published As

Publication number Publication date
MD480Z (en) 2012-09-30
MD480Z5 (en) 2012-09-30

Similar Documents

Publication Publication Date Title
MX2016013529A (en) Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof.
EA201691151A1 (en) CONNECTIONS FOR THE TREATMENT OF PATIENTS WITH ROS1-MUTANT CANCER CELLS
NZ630589A (en) Methods of treating alzheimer’s disease and pharmaceutical compositions thereof
EA201590450A1 (en) SULFAMOIL-Arylamides and Their Use as Medicinal Products for the Treatment of Hepatitis B
PH12016501357B1 (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
EA201492005A1 (en) BENZAMIDE DERIVATIVES TO INHIBIT ACTIVITY ABL1, ABL2 AND BCR-ABL1
EA201390984A1 (en) HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA
MX2013008056A (en) 1,4-oxazepines as bace1 and/or bace2 inhibitors.
MX2014008021A (en) Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain.
RU2013150861A (en) PHARMACEUTICAL COMPOSITION CONTAINING GLUTARIMIDE DERIVATIVES AND THEIR APPLICATION FOR TREATMENT OF EOSINOPHILIC DISEASES
MX2022005985A (en) Pyrazolo-heteroaryl derivative, preparation method therefor, and medical use thereof.
MY186647A (en) Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors
MX2013002208A (en) Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes.
UA109359C2 (en) TREATMENT OF SKIN DISEASES AND STATES
MD480Y (en) Method for treating acute ulcerative nonspecific colitis
SA518392177B1 (en) Perfusion system
MX2019007360A (en) Azabicyclo-substituted triazole derivative, preparation method thereof, and application of same in medicine.
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
EA201690903A1 (en) TREATMENT GLAUCOMA USING LAQUINIMODE
RU2012103957A (en) METHOD OF TREATMENT AND PREVENTION OF NASAL OBSTRUCTION IN PATIENTS WITH POLYZAL RHINOSINUSITIS
MX2024005304A (en) Substituted phenylpropionic acid derivative and use thereof.
MD596Y (en) Method for treating the chronic viral hepatitis C
MX2015016930A (en) Use and pharmaceutical compositions containing coordination compounds with redox activity that is coordinated with the cellular dna.
UA95037U (en) METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS
UA69870U (en) Method for the treatment of vegetative sensory polyneuropathy in patients with vibration disease

Legal Events

Date Code Title Description
ND4Y Validity of short term patent extended [from 6 to 10 years]

Expiry date: 20210707

KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees